Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety Study of 610 in Patients With Severe Asthma — Stella

Home/Asthma/Efficacy and Safety Study of 610 in Patients With Severe Asthma

View on ClinicalTrials.gov

Recruiting

Back to Asthma trials

Efficacy and Safety Study of 610 in Patients With Severe Asthma

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Shanghai General Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Large-scale testing

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Enrollment target

~480 participants

Started

June 2024

Primary completion

February 2027

Age range

18 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.